Rachel Dankner

27.8k total citations · 2 hit papers
110 papers, 2.9k citations indexed

About

Rachel Dankner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rachel Dankner has authored 110 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Molecular Biology and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rachel Dankner's work include Metabolism, Diabetes, and Cancer (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Diabetes Treatment and Management (16 papers). Rachel Dankner is often cited by papers focused on Metabolism, Diabetes, and Cancer (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Diabetes Treatment and Management (16 papers). Rachel Dankner collaborates with scholars based in Israel, United States and Canada. Rachel Dankner's co-authors include Jesse Roth, Michael H. Shanik, Yuping Xu, J Škrha, Yehiel Zick, Angela Chetrit, Angela Chetrit, Liraz Olmer, Michael Bergman and Ilya Novikov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Rachel Dankner

103 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin Resistance and Hyperinsulinemia

2008 589 citations Rachel Dankner, Jesse Roth et al. profile →
Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes

2024 62 citations Rachel Dankner, Havi Murad et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Dankner Israel	28	895	723	604	448	417	110	2.9k
Susanna Morano Italy	35	1.1k 1.2×	681 0.9×	460 0.8×	320 0.7×	533 1.3×	132	3.6k
Chiu-Shong Liu Taiwan	32	692 0.8×	323 0.4×	620 1.0×	536 1.2×	387 0.9×	101	2.9k
Vincenzo Triggiani Italy	33	1.7k 1.9×	659 0.9×	460 0.8×	340 0.8×	393 0.9×	183	3.6k
Nam H. Cho South Korea	37	905 1.0×	545 0.8×	671 1.1×	451 1.0×	221 0.5×	87	3.9k
Margaretha Persson Sweden	39	812 0.9×	518 0.7×	500 0.8×	628 1.4×	1.0k 2.5×	107	4.0k
Ningjian Wang China	38	1.3k 1.4×	619 0.9×	737 1.2×	938 2.1×	492 1.2×	211	4.5k
Mian Li China	30	828 0.9×	605 0.8×	462 0.8×	749 1.7×	623 1.5×	159	3.5k
Cornelia Huth Germany	36	703 0.8×	650 0.9×	615 1.0×	613 1.4×	441 1.1×	86	2.9k
Konstantinos A. Toulis Greece	35	1.6k 1.8×	600 0.8×	532 0.9×	677 1.5×	539 1.3×	109	4.3k
Leena Moilanen Finland	27	940 1.1×	294 0.4×	536 0.9×	410 0.9×	578 1.4×	67	2.5k

Countries citing papers authored by Rachel Dankner

Since Specialization

Citations

This map shows the geographic impact of Rachel Dankner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Dankner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Dankner more than expected).

Fields of papers citing papers by Rachel Dankner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Dankner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Dankner. The network helps show where Rachel Dankner may publish in the future.

Co-authorship network of co-authors of Rachel Dankner

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Dankner. A scholar is included among the top collaborators of Rachel Dankner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Dankner. Rachel Dankner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leibowitz, Avshalom, et al.. (2026). Glucagon-like peptide-1 receptor agonists and Wernicke encephalopathy: A pharmacovigilance study and literature review. Clinical Nutrition. 57. 106571–106571.

Orenstein, Liat, et al.. (2025). A Prospective Study on Potentially Inappropriate Drug Use and All‐Cause Mortality in Community‐Dwelling Older Adults. Journal of the American Geriatrics Society. 73(9). 2828–2838. 2 indexed citations

Moshkovitz, Yaron, et al.. (2024). Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery. Mayo Clinic Proceedings. 99(5). 766–779. 1 indexed citations

Singer, Pierre, et al.. (2024). A historical cohort study on predictors for successful weaning from prolonged mechanical ventilation and up to 3-year survival follow-up in a rehabilitation center. Respiratory Medicine. 227. 107636–107636. 1 indexed citations

Ben‐Avraham, Sivan, Angela Chetrit, Laurence S. Freedman, et al.. (2024). Methodology and challenges for harmonization of nutritional data from seven historical studies. Nutrition Journal. 23(1). 88–88. 2 indexed citations

Goldman, Adam, Boris Fishman, Gilad Twig, et al.. (2023). The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study. Cardiovascular Diabetology. 22(1). 16–16. 24 indexed citations

Dankner, Rachel, et al.. (2022). High variation between healthcare professionals in nutrition therapy plans of patients with feeding tubes admitted to a long‐term rehabilitation center from an acute‐care hospital. Nutrition in Clinical Practice. 38(2). 425–433.

Dankner, Rachel, et al.. (2022). Association between Self-Classification of COVID-19 Risk Levels and Adverse Lifestyle Changes among Physically Active Older Adults Following the Coronavirus Outbreak. International Journal of Environmental Research and Public Health. 19(12). 7039–7039. 3 indexed citations

Goldman, Adam, Emanuel Raschi, Tali Cukierman‐Yaffe, et al.. (2021). Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study. European Journal of Preventive Cardiology. 29(9). 1334–1342. 25 indexed citations

10.

Goldman, Adam, David Bomze, Rachel Dankner, et al.. (2020). Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports. British Journal of Clinical Pharmacology. 87(3). 1432–1442. 42 indexed citations

11.

Bergman, Michael, Ram Jagannathan, Martin Buysschaert, et al.. (2017). Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?. Endocrine. 55(3). 697–701. 9 indexed citations

12.

Dankner, Rachel, Paolo Boffetta, Lital Keinan‐Boker, et al.. (2016). Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men. Diabetologia. 59(8). 1683–1691. 30 indexed citations

13.

Orenstein, Liat, Angela Chetrit, & Rachel Dankner. (2016). Healthy Lifestyle Pattern is Protective Against 30-Yr Cancer Incidence in Men and Women: A Cohort Study. Nutrition and Cancer. 68(3). 410–419. 8 indexed citations

14.

Song, Xin, Ádám G. Tabák, John Yudkin, et al.. (2015). Obesity attenuates gender differences in cardiovascular mortality. UCL Discovery (University College London).

15.

Geulayov, Galit, Yaacov Drory, Ilya Novikov, & Rachel Dankner. (2014). Sense of coherence and 22-year all-cause mortality in adult men. Journal of Psychosomatic Research. 78(4). 377–383. 16 indexed citations

16.

Greenberg, Dan, Gary Ginsberg, Arnona Ziv, et al.. (2013). The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke Survivors. Value in Health. 16(7). A533–A534. 1 indexed citations

17.

Dankner, Rachel, et al.. (2013). A simplified severity score for acute asthma exacerbation. Journal of Asthma. 50(8). 871–876. 8 indexed citations

18.

Dankner, Rachel, Angela Chetrit, Havi Murad, et al.. (2010). Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent manner. Metabolism. 59(12). 1767–1774. 9 indexed citations

19.

Magnezi, Racheli, et al.. (2005). Comparison of Health Care Services for Career Soldiers Throughout the World. Military Medicine. 170(12). 995–998. 9 indexed citations

20.

Dankner, Rachel, et al.. (1967). USE OF BETATRONS IN DEFECTOSCOPY OF REFRACTORY CONSTRUCTION MATERIALS.. PubMed. 141(1). 89–92, 123.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact